Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/23/14 → 1/23/23 |
Funding
- Millennium Pharmaceuticals, Inc (Prot #C34001)
Prot #C34001: An Open-Label, Dose Escalation, Phase 1, First-in-Human Study of TAK-659 in Adult Patients with Advanced Solid Tumor and Lymphoma Malignancies
- Karmali, Reem (PD/PI)
- Kaplan, Jason B (Other)
Project: Research project